Garland J. Scott bought ELVN
January 7, 2026 · Form 4 insider transaction
Garland J. Scott bought 59,372 shares of Enliven Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
59,372
Price
$0.00
Total value
N/A
InsiderGarland J. Scott
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 7, 2026
Filing dateJanuary 9, 2026
Shares owned after59,372
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/36th of the shares subject to the option will vest on February 7, 2026 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date.